Approval · Notice of Compliance 19081 · 2017
CLÉO -35: Notice of Compliance 19081
Issued March 20, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19081
- Date
- March 20, 2017
- Company
- Altius Healthcare IncMontmagny, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
- Canadian reference product
- DIANE-35 (Bayer Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLÉO -35 | 02436736 | Marketed |
Medicinal ingredients
- ETHINYL ESTRADIOL 0.035 MG per TAB
- CYPROTERONE ACETATE 2 MG per TAB